Cytokinetics(CYTK.US)

Event Tracking

Dec30

Celldyne's EVP Sells Company Stock

21:35

Dec25

Cellectricon CYTK Receives FDA Approval for MYQORZO, First Therapy for Obstructive Hypertrophic Cardiomyopathy

20:12

Dec24

Squarepoint Ops LLC Reduced Stake in Cell Therapeutics

10:08

Dec23

Cellular Dynamics Director Wendell Wierenga Reports Disposal of Common Stock

21:14

Dec22

Cardio Dynamics Approved by FDA to Launch MYQORZO Tablets for oHCM

11:43

Barclays Analyst Maintains Buy Rating on Celldyn

10:11

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.936 M, Net Income -306.18 M, EPS -2.5518

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 66.77 M, Net Income -134.37 M, EPS -1.1248

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.579 M, Net Income -161.38 M, EPS -1.3618

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change